Absci (ABSI) EBT Margin (2020 - 2026)
Absci's (ABSI) quarterly EBT Margin came in at 13758.6% in Q1 2026, down 1152366.0% year-on-year from N/an in Q1 2025, and down 200.87% quarter-over-quarter from 4572.92% in Q4 2025.
Absci (ABSI) EBT Margin (2020 - 2026) Analysis & Trends
Absci has disclosed EBT Margin across 7 years of filings, most recently posting 13758.6% for Q1 2026.
- EBT Margin for Q1 2026 came in at 13758.6%, down 1152366.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6445.81% (down 421480.0% YoY), and the FY2025 annual result was 4111.21%, down 183870.0% from the prior year.
- EBT Margin came in at 13758.6% for Q1 2026 at Absci, down from 4572.92% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 1163.82% in Q3 2022 to a low of 16369.67% in Q4 2022.
- The 5-year median for EBT Margin is 2951.61% (2023), against an average of 4996.36%.
- Peak annual rise in EBT Margin reached 3153357 bps in 2022, while the deepest fall reached 1250104 bps in 2022.
- Absci's EBT Margin stood at 16369.67% in 2022, then surged by 58 bps to 6951.78% in 2023, then jumped by 37 bps to 4355.19% in 2024, then declined by 5 bps to 4572.92% in 2025, then sank by 201 bps to 13758.6% in 2026.
- The last three EBT Margin figures came in at 13758.6% (Q1 2026), 4572.92% (Q4 2025), and 7566.67% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -13,758.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,758.60% |
| Dec 31, 2025 | -4,572.92% |
| Sep 30, 2025 | -7,566.67% |
| Jun 30, 2025 | -5,132.88% |
| Mar 31, 2025 | -2,234.94% |
| Dec 31, 2024 | -4,355.19% |
| Sep 30, 2024 | -1,608.52% |
| Jun 30, 2024 | -1,948.82% |
| Mar 31, 2024 | -2,445.77% |
| Dec 31, 2023 | -6,951.78% |
| Sep 30, 2023 | -2,951.61% |
| Jun 30, 2023 | -1,237.33% |
| Mar 31, 2023 | -1,839.87% |
| Dec 31, 2022 | -16,369.67% |
| Sep 30, 2022 | -1,163.82% |
| Jun 30, 2022 | -2,889.22% |
| Mar 31, 2022 | -7,910.41% |
| Dec 31, 2021 | -3,868.63% |
| Sep 30, 2021 | -1,822.81% |
| Jun 30, 2021 | -34,422.79% |